Mobile

Immunogenicity of the Investigational Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Comparison with the Intramuscular Reference Vaccine Vaxigrip in the Elderl...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-002366-18

Immunogenicity of the Investigational Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Comparison with the Intramuscular Reference Vaccine Vaxigrip in the Elderly

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To demonstrate that the intradermal ID investigational vaccine induces a better immunogenicity than the intramuscular IM reference vaccine in terms of seroprotection rate after the first vaccination.

Critère d'inclusion

  • Vaccination of elderly subjects aged 60 years and over with inactivated, split-virion inf luenza vaccine administered by the intradermal route using Vaxigrip as IM reference vaccine

Liens